|
Advisers | Academic
Prof Mike Spyer, UCL Vice-Provost Enterprise
Professor Spyer is a neuroscientist with extensive research accomplishments in the field of the central nervous control of cardiorespiratory function. He became Sophia Jex-Blake Professor of Physiology at the Royal Free Hospital School of Medicine in 1980. He was appointed Dean of the Royal Free & University College Medical School in 2001, and Vice-Provost (Biomedicine) of UCL in 2002. He currently serves as a non-executive Director of the London NHS. In 2006, Professor Spyer was appointed UCL’s first Vice-Provost (Enterprise), with a mission to develop UCL’s Knowledge Transfer strategy, together with formulating an effective programme for the promotion of entrepreneurship and innovation in UCL for all staff and students.
Prof Bernard Buxton, UCL Dean of Engineering Sciences
Bernard Buxton has been Professor of Information Processing Systems in the Department of Computer Science at UCL since 1994. His career includes, prior to UCL, six years as a student and seven years as a theoretical solid state physics researcher and teacher at the Universities of Cambridge and Bristol, and thirteen years in industrial R&D, during which he has produced almost 40 papers in physics and over 100 in his main research areas in computer science, in: computer vision; image processing; 3-D surface imaging especially of the human head and body; the synergy of computer vision and graphics; level of detail and visualisation; statistical modelling and pattern recognition, in particular for applications to bioinformatics and commerce.
Bernard has been very active in establishing the field of computer vision research, for over eight years served on the Governing Body of the BBSRC’s Silsoe Research Institute and has held many positions of responsibility in the Department and at UCL, in particular since 2004 as Director of UCL’s ~£18M+ Collaborative Training Account and 2005 as Dean of the Faculty of Engineering Sciences comprising ~200 academic staff and an annual turnover of ~£55M.
Dr Eli Keshavarz-Moore, UCL Reader in Biochemical Engineering
Eli Keshavarz-Moore’s research interest is in the bioprocessing of complex macromolecules with therapeutic promise including fusion proteins, antibody fragments (monoclonal and polyclonal), artificial chromosomes and phages; and cells including microbial, mammalian and fungal systems as well as transgenic materials. Her transgenic research is currently aimed at using micro biochemical engineering to address the design of transgenic products in plants. This has been in collaboration with St Georges Hospital and Birmingham University.
Since 2000, Eli Keshavarz-Moore has led the development and implementation of innovative enterprise training at the bioprocessing/life sciences interface. The training program encompasses a range of courses at undergraduate and postgraduate levels and has extended to include business enterprise for industry in the healthcare and biotechnology sectors. As a result, over 600 students have been trained from across UCL, including the Faculties of Engineering Sciences, Life Sciences and Medicine together with a mix of post-experience delegates from other institutions including the London Business School.
Advisers | Angel Investor
Martin Bloom, Advisory Board Member and Special Advisor for Asia at Argopolo Capital Partners
Martin Bloom helps build the high growth companies of tomorrow through a combination of mentoring entrepreneurs and senior management, joining the Boards of companies to assist them in creating and driving forward their strategies, and by investing in private companies that have high growth potential. Martin was a formerly a corporate strategist at Unilever and has 25 years experience in strategic partnering, technology commercialisation and business strategy. Martin has a B.Sc. (Soc.Sc.) Honours in Economics from the University of Southampton and an M.Sc. in the History of Science jointly from Imperial College and University College, London.
Advisers | Entrepreneurs
Prof Philip Treleaven, UCL Spinout & Business Links Co-ordinator (focus: Early-stage Start-ups)
Professor Treleaven has been in the forefront at UCL in establishing courses and an infrastructure to encourage Entrepreneurship. This includes the highly popular 30-lecture foundation course Introduction to Business & Entrepreneurship. The Computer Science Department, to encourage people to exploit their research, also allows staff and PhD students to start companies 'at their desk'. A number of companies are being incubated in the Department. Philip has published a number of books in the area and led the UK Government (DTI) Mission to the USA, Israel, Taiwan etc. study government schemes to support and encourage entrepreneurship. Philip is also the Director of three companies and serves on the Advisory Board of a Venture Capital company.
Dr Andrew Lynn, Founder & CEO, Orthomimetics Ltd (focus: Student Entrepreneurship)
Andrew Lynn is Founder and Chief Executive Officer of Orthomimetics Limited, a UK company in the field of orthopaedics and regenerative medicine. His academic-research and commercial-development experience spans over ten years and four countries, and includes the fundraising, initiation, management, and implementation of product-focused programmes involving artificial prostheses for joint replacement and tissue regeneration scaffolds for orthopaedic, neurosurgical, and thoracic applications. He has worked extensively with world-renowned surgeons on initiatives to develop regenerative medical treatments for hard and soft tissues, including, in Kyoto, Japan, a preclinical development programme for a nerve-regeneration product currently in use for over 500 patients. Dr Lynn founded Orthomimetics on the basis of his PhD research on the design and development of a tissue regeneration scaffold for articular-joint defects conducted in conjunction with a team of colleagues from the University of Cambridge, Massachusetts Institute of Technology, and Harvard University.
Dr Anne Lane, UCL Business Ltd (focus: Woman in Entrepreneurship)
Dr. Anne Lane has a BSc and PhD in biochemistry and genetics from UCL and an Executive MBA from Molson Business School, Montreal. After research at UCL and Harvard Medical School, Anne worked for RTP Pharma Inc in Montreal, out-licensing and preparing valuations of the company’s portfolio for public listing. Anne joined UCL Ventures in 2000 and acted as consultant for the National Technology Transfer Centre in the US. She is now Executive Director of UCL Business PLC, a wholly-owned subsidiary of UCL and acts as director and interim CEO on several of UCLB’s spin out companies. Anne is also on the council of the Licensing Executives Society for Britain and Ireland.
|
+44 (0)20 7679 2000 - Copyright © 1999-2008 UCL